|
|
Article: Eden Biodesign Chosen by Omnio Healer AB for cGMP Production of Clinical Trial Product
- Article from:
- Wireless News
- Article date:
- August 12, 2009
CopyrightProvided by ProQuest LLC. (Hide copyright information)
|
Wireless News
08-12-2009
Eden Biodesign Chosen by Omnio Healer AB for cGMP Production of Clinical Trial Product
Type: News
Eden Biodesign and Omnio Healer AB, a company that develops novel therapies for wound healing and anti-infection, announced that they have entered into a partnership agreement.
Based on a novel therapeutic concept for wound healing and anti- infection, Omnio Healer is developing drug candidates with potent pro-inflammatory functions, and under this new agreement, Eden Biodesign will provide process development and cGMP production services relating to Omnio Healer's lead recombinant protein candidate, the group noted in a release. Indeed, the agreement with Eden ...
Related newspaper, magazine, and journal articles:
|
|
Article: Oxford Expression Technologies and Eden Biodesign ...
Vaccine Weekly;
February 18, 2009 ;
700+ words
... ... expression products and services, and Eden Biodesign, an expert provider of biopharmaceutical ... will offer its customers access to Eden Biodesign's process development, clinical ... development services. In return, Eden Biodesign's customers will have access to OET ...
|
|